CANbridge Pharmaceuticals Inc. (1228.HK)

HKD 0.16

(0.65%)

Revenue Summary of CANbridge Pharmaceuticals Inc.

  • CANbridge Pharmaceuticals Inc.'s latest annual revenue in 2023 was 102.87 Million CNY , up 30.26% from previous year.
  • CANbridge Pharmaceuticals Inc.'s latest quarterly revenue in 2024 Q2 was 22.39 Million CNY , down 0.0% from previous quarter.
  • CANbridge Pharmaceuticals Inc. reported a annual revenue of 78.97 Million CNY in annual revenue 2022, up 153.43% from previous year.
  • CANbridge Pharmaceuticals Inc. reported a annual revenue of 31.16 Million CNY in annual revenue 2021, up 158.98% from previous year.
  • CANbridge Pharmaceuticals Inc. reported a quarterly revenue of 22.39 Million CNY for 2024 Q1, down -25.12% from previous quarter.
  • CANbridge Pharmaceuticals Inc. reported a quarterly revenue of 29.91 Million HKD for 2023 Q3, up 38.95% from previous quarter.

Annual Revenue Chart of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Revenue of CANbridge Pharmaceuticals Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 102.87 Million CNY 30.26%
2022 78.97 Million CNY 153.43%
2021 31.16 Million CNY 158.98%
2020 12.03 Million CNY 719.06%
2019 1.46 Million CNY 0.0%

Peer Revenue Comparison of CANbridge Pharmaceuticals Inc.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 78.777%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 98.067%